Adam Reynolds


  • > Former stockbroker with over 35 years’ experience within the UK financial services sector
  • > Founded Hansard Group Plc which was admitted to trading on AIM in 2000
  • > Currently a director of several AIM traded companies - non-executive director of EKF Diagnostics Holdings Plc, Optibiotix Plc and Premaitha Health Plc
  • > Director of a number of private companies

Erik Henau

Chief Executive Officer

  • > In excess of 35 years global sales and marketing experience gained in OTC medical devices including laboratory diagnostics and life sciences
  • > Experience at Amersham International and Oxoid in a clinical environment as well as at Unipath and Alere as the International OTC Director
  • > Set up Adaxis Limited which operated in the sexual and reproductive health area to commercialise innovative products in the medium term

Barbara Spurrier

Chief Financial Officer

  • > Fully qualified certified accountant (FCCA) with over 35 years finance experience in numerous sectors
  • > Main board director on four AIM quoted Plc’s, heading the revenue recognition committee of the board for one of these companies

Dr Mark Wyatt

Non-executive Director

  • > Investment Director at Mercia Technologies Plc and has particular expertise in healthcare and clean technology sectors
  • > Previously Bioscience Ventures Manager at Imperial Innovations responsible for the formation of new, and management of existing, early stage portfolio companies.

Neil Mesher

Non-executive Director

  • Neil has more than 25 years of global experience within the healthcare and consumer electronics industries. He is currently CEO of Philips for the UK and Ireland and is on the Board of the Association of British Healthcare Industries (ABHI), from which he led the industry’s response to the NHS’s “5 Year Forward View”, assessing opportunities for greater integration between industry and the healthcare system. Neil is also a member of the Governments Life Science Industrial Strategy Board, representing the interests of the medical technology sector with other senior leaders from across healthcare.